5,236 reports of this reaction
3.9% of all SOMATROPIN reports
#6 most reported adverse reaction
DEVICE ISSUE is the #6 most commonly reported adverse reaction for SOMATROPIN, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 5,236 FDA adverse event reports linking SOMATROPIN to DEVICE ISSUE. This represents approximately 3.9% of all 133,576 adverse event reports for this drug.
SOMATROPIN has an overall safety score of 78 out of 100. Patients taking SOMATROPIN who experience device issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEVICE ISSUE is moderately reported among SOMATROPIN users, representing a notable but not dominant share of adverse events.
In addition to device issue, the following adverse reactions have been reported for SOMATROPIN:
The following drugs have also been linked to device issue in FDA adverse event reports:
DEVICE ISSUE has been reported as an adverse event in 5,236 FDA reports for SOMATROPIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEVICE ISSUE accounts for approximately 3.9% of all adverse event reports for SOMATROPIN, making it a notable side effect.
If you experience device issue while taking SOMATROPIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.